In diseases satisfactorily treated with anti-IL-1 therapy, such as sepsis or autoinflammatory syndromes, the blood concentrations of IL-1β are very low and usually not detected (33, 43). This evidence concerns the gene IL1B and autoinflammatory syndrome.